IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.562
NA - Nord America 3.823
AS - Asia 2.576
SA - Sud America 1.051
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
AN - Antartide 1
Totale 12.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.732
RU - Federazione Russa 1.671
SG - Singapore 1.157
BR - Brasile 929
IE - Irlanda 804
CN - Cina 606
SE - Svezia 601
IT - Italia 595
HK - Hong Kong 363
VN - Vietnam 185
DE - Germania 173
PL - Polonia 122
GB - Regno Unito 114
UA - Ucraina 104
FI - Finlandia 103
FR - Francia 92
AT - Austria 76
IN - India 74
AR - Argentina 39
CA - Canada 39
MX - Messico 35
BD - Bangladesh 30
BE - Belgio 27
TR - Turchia 24
ZA - Sudafrica 24
IQ - Iraq 22
MA - Marocco 22
EC - Ecuador 20
NL - Olanda 20
ID - Indonesia 19
UZ - Uzbekistan 16
JP - Giappone 15
CO - Colombia 14
UY - Uruguay 12
ES - Italia 11
VE - Venezuela 11
CZ - Repubblica Ceca 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
CL - Cile 7
DZ - Algeria 7
PE - Perù 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
GE - Georgia 5
KZ - Kazakistan 5
LT - Lituania 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
LV - Lettonia 4
PK - Pakistan 4
SA - Arabia Saudita 4
SC - Seychelles 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
EU - Europa 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
HN - Honduras 2
KW - Kuwait 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
RO - Romania 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
Totale 12.097
Salva come PNG Salva come JPEG
Città #
Moscow 846
Dublin 804
Chandler 547
Singapore 536
Ashburn 499
Nyköping 433
Hong Kong 363
Dallas 350
Beijing 316
Messina 247
Jacksonville 228
Princeton 127
Warsaw 120
Medford 114
Los Angeles 94
Dearborn 90
Des Moines 90
Cambridge 81
Ann Arbor 71
São Paulo 70
Vienna 70
Ho Chi Minh City 62
The Dalles 59
Buffalo 58
Redondo Beach 51
New York 50
Boardman 39
Hanoi 37
Lancaster 33
Munich 31
Rio de Janeiro 31
Jinan 30
San Mateo 30
Tianjin 27
Brussels 23
Belo Horizonte 22
Hyderabad 22
Frankfurt am Main 21
Montreal 21
Rome 21
Santa Clara 21
Stockholm 21
Aversa 20
Curitiba 19
Wilmington 18
Brasília 17
Brooklyn 17
Campinas 16
Chicago 15
Pune 15
Seattle 15
Tashkent 15
Houston 14
San Francisco 14
Shenyang 14
Denver 13
Johannesburg 13
Lauterbourg 13
Porto Alegre 13
Tokyo 13
Woodbridge 13
Düsseldorf 12
London 12
Montpellier 12
Atlanta 11
Boston 11
Mexico City 11
Taizhou 11
Amsterdam 10
Augusta 10
Baghdad 10
Chennai 10
Dong Ket 10
Guarulhos 10
Haikou 10
Helsinki 10
Montevideo 10
Nanjing 10
Palermo 10
Phoenix 10
Zhengzhou 10
Bari 9
Biên Hòa 9
Hebei 9
Manaus 9
Poplar 9
Uberlândia 9
Ankara 8
Catania 8
Da Nang 8
Haiphong 8
Milan 8
Mumbai 8
Orem 8
Salvador 8
Turku 8
Bexley 7
Brno 7
Francofonte 7
Nuremberg 7
Totale 7.457
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 189
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 161
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 149
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 147
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 139
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 138
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 135
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 134
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 132
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 131
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 130
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 127
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 125
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 124
Design and synthesis of novel isoxazole-based HDAC inhibitors 122
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 122
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 122
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 118
Evaluation of curcumin irreversibility 118
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 118
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 116
Role of the microbiota in hematologic malignancies. 116
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 116
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 115
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 115
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 113
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 113
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 113
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 112
Development of novel amides as non covalent inhibitors of immunoproteasome 112
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 112
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 110
Falcipain-2 inhibitors 108
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 108
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 107
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 106
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 105
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 105
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 105
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 103
Composti antitumorali 103
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 102
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 102
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 101
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 101
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 101
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 100
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 99
Development of peptidomimetic boronates as proteasome inhibitors 99
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 99
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 99
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 98
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 97
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications 95
Glutamate Binding-Site Ligands of NMDA Receptors 95
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 94
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 93
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 93
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 93
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 93
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 92
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 91
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 90
Development of peptidomimetic boronates as proteasome inhibitors 90
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 90
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 90
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 88
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 88
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 87
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 86
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 86
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 86
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 85
Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives 85
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 85
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 85
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 85
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 84
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 84
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 84
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 83
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 83
Novel peptidomimetic cysteine protease inhibitors as antimalarial agents 81
A proteomic platform unveils the brain glycogen phosphorylase as a potential metabolic target for glioblastoma multiforme 81
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 80
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 80
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 79
Recent Advances in Nanotherapeutics for Multiple Myeloma 79
Effect of mammalian SERCA inhibitors on Plasmodium falciparum growth in vitro 78
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 78
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 78
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 77
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 76
Novel 2H-Isoquinolin-3-ones Falcipain-2 Inhibitors as Antimalarial Agents 76
NMR conformational analysis in solution of a potent class of cysteine proteases inhibitors 76
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 76
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 74
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 73
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 73
Synthesis and pharmacological evaluation of α4β2 nicotinic ligands with a 3-fluoropyrrolidine nucleus 72
Totale 10.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 85 23 55 81 107 29 34
2021/2022771 11 104 6 48 14 6 65 25 7 53 133 299
2022/20232.281 182 201 103 179 141 229 36 148 959 4 76 23
2023/2024589 69 72 41 143 55 48 6 8 3 62 33 49
2024/20252.463 41 21 44 157 92 56 75 460 676 175 236 430
2025/20264.458 306 531 538 656 689 1.738 0 0 0 0 0 0
Totale 12.652